CZMWF (CZMWF) Stock Price & Analysis
CZMWF (CZMWF) rose 0.00% to USD 33.5 as of July 26, 2026 at 12:49 UTC, according to Nexqual real-time market data.
CZMWF last closed at USD 33.5; the session ranged USD 33.6–33.6 on volume of 100 shares. Market capitalization is $2.93B, with a 52-week range of USD 26.42–59.4 (PNK). Source: Nexqual, July 26, 2026 at 12:49 UTC.
Key Statistics (as of July 26, 2026 at 12:49 UTC)
| Price | USD 33.5 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 33.5 |
| Open | USD 33.6 |
| Day Range | USD 33.6 – 33.6 |
| 52-Week Range | USD 26.42 – 59.4 |
| Volume | 100 shares |
| Market Cap | $2.93B |
| Exchange | PNK |
Technical Analysis (CZMWF)
Nexqual's technical model rates CZMWF "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 26, 2026 at 12:49 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 64.78 (neutral) |
| vs SMA50 | Above (USD 31.18) |
| MACD | 0.76 (positive) |
Analyst Ratings (CZMWF)
Wall Street analysts rate CZMWF "None", per Nexqual as of July 26, 2026 at 12:49 UTC.
| Consensus Rating | None |
|---|
Earnings (CZMWF)
| Next Earnings Date | 2026-08-06 |
|---|---|
| Revenue Estimate | $540.90M |
Source: Nexqual, July 26, 2026 at 12:49 UTC.
Financials & Fundamentals (CZMWF)
| Total Revenue | $2.17B |
|---|---|
| Revenue Growth (YoY) | -6.40% |
| Gross Margin | +51.28% |
| Operating Margin | +4.86% |
| Profit Margin | +4.38% |
| ROE | +4.54% |
| Debt / Equity | 27.56 |
| Current Ratio | 2.43 |
| Total Cash | $23.90M |
| Total Debt | $580.95M |
| Free Cash Flow | $88.17M |
Source: Nexqual, July 26, 2026 at 12:49 UTC.
Financial Health Score (CZMWF)
Nexqual rates CZMWF's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 12:49 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 51%, operating 5% |
| Balance Sheet | Strong — $24M cash vs $581M debt |
| Cash Flow | Mixed — FCF $88M, slim 4.0% margin |
| Efficiency | Weak — ROE 5%, ROA 2.7% |
Ownership (CZMWF)
| Insider Ownership | +59.23% |
|---|---|
| Institutional Ownership | +18.05% |
| Shares Outstanding | 87.54M |
| Float | 34.68M |
Source: Nexqual, July 26, 2026 at 12:49 UTC.
Leadership (CZMWF)
CZMWF is led by Andreas Pecher (age 54), Interim Chairman of the Management Board & Interim CEO, per Nexqual as of July 26, 2026 at 12:49 UTC.
| Interim Chairman of the Management Board & Interim CEO | Andreas Pecher (age 54) |
|---|---|
| CFO & Member of the Management Board | Justus Felix Wehmer (age 60) |
| Chief Operating Officer | Stefanie Spanagel |
| Director of Investor Relations | Sebastian Frericks |
| Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc. | Andrew Chang |
Major Backers & Investors (CZMWF)
Notable institutional backers of CZMWF include AIM Intl Mutual Fd.s -Invesco Intl Small-Mid Company Fd., DFA INVESTMENT TRUST CO-The Continental Small Company Series, INVESTMENT MANAGERS SERIES TRUST-EuroPac International Value Fund, according to Nexqual as of July 26, 2026 at 12:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AIM Intl Mutual Fd.s -Invesco Intl Small-Mid Company Fd. | 1.19% |
| DFA INVESTMENT TRUST CO-The Continental Small Company Series | 0.12% |
| INVESTMENT MANAGERS SERIES TRUST-EuroPac International Value Fund | 0.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.23% |
| BlackRock | 0.49% |
Source: Nexqual, July 26, 2026 at 12:49 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CZMWY | Carl Zeiss Meditec AG | USD 31.4 | ▼ 2.04% |
| CLPBF | COLOPLAST | USD 64 | ▲ 0% |
| HOCPF | HOYA CORP | USD 154.17 | ▲ 0% |
| CHEOY | CochLear Ltd. | USD 39.04 | ▲ 0.03% |
| CHEOF | CochLear Ltd. | USD 78.95 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 12:49 UTC. This page is informational and not investment advice.